NCT02491931View on ClinicalTrials.gov

Oral Glutamine in Cardiopulmonary Bypass

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Ischemic Heart Disease
Interventions
DIETARY_SUPPLEMENT

Supplement/placebo intake

Patients will receive either GLN or placebo prior to cardiovascular surgery under extracorporeal circulation, during 3 days and one final dose 4 hours prior to anesthesia.

All Listed Sponsors
lead

Instituto Mexicano del Seguro Social

OTHER_GOV

NCT02491931 - Oral Glutamine in Cardiopulmonary Bypass | Biotech Hunter | Biotech Hunter